Some patients have certain clinical needs that can’t be met by licensed medicinal products. The law allows the manufacture and supply of unlicensed medicines which are called special orders (or specials) that meet these clinical needs. Special orders must be produced in the UK by manufacturers who hold a Specials License issued by the MHRA.
We provide information about prescribing of special order products in general practice in England. Using data source ePACT2.
National level information
Trends in prescribing and spending in the last 25 months:
Quarterly data available from June 2018:
CCG level information
Comparison of spending on Special Order products using the latest available quarterly data.
CCG prescribing and spending for the latest available 25 months.
Comparison of spending on special order products for the latest available quarterly data.
What the data takes into account
The data includes Special Order Products listed in Part VIIIB of the Drug Tariff and non- Drug Tariff Special Order Products.
Some special order items may be "imported" but are listed as Special Order Products as NHS Prescription Services do not hold an indicator for "imported" items on our internal systems.
Changes to the reimbursement of special order products
With effect from November 2011 prescriptions, certain special order products have been reimbursed according to Drug Tariff Part VIIIB Arrangements for Payment for Specials and Unlicensed Medicines. This means that certain products formerly categorised as special order products are now categorised as Drug Tariff Special Order Products.
Any products indicated (Old) are those items which were previously Special Order Products but are now available either as Drug Tariff Special Order or licensed products.
Any products indicated (DT Old) are those items which are no longer a Drug Tariff Special Order but are still considered to be a Special Order Product or available as a licensed product.